Marker Therapeutics is trading 6.96% up at $1.23 in after-hours trading, apparently amid broader risk-on sentiment rather than a confirmed company catalyst.

  • It closed at $1.15 on September 11, 2026.
  • No company-specific announcement was identified for September 10 or September 11, and the company’s official release page showed no new catalyst.
  • The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average each gained more than 0.5% during the session.